Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
|
Device | EUFLEXXA |
Generic Name | Acid, hyaluronic, intraarticular |
Applicant | FERRING PHARMACEUTICALS, INC. 100 INTERPACE PARKWAY PARSIPPANY, NJ 07054 |
PMA Number | P010029 |
Supplement Number | S037 |
Date Received | 02/05/2024 |
Decision Date | 03/01/2024 |
Product Code |
MOZ |
Advisory Committee |
Orthopedic |
Supplement Type | 30-Day Notice |
Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement modifications to the purification process utilized in the manufacturing of NaHA bulk intermediate batches to optimize the ability to remove contaminants and to improve yield. Proposed modifications include increasing the amount of activated charcoal, Celatom and water for injection for the 1 kg and 1.5 kg batch sizes as well as two additional ethanol washes for the 1.5 kg batch size |
|
|